Kezar Life Sciences (KZR) Net Income (2021 - 2025)
Kezar Life Sciences (KZR) has disclosed Net Income for 5 consecutive years, with -$14.4 million as the latest value for Q4 2025.
- For Q4 2025, Net Income rose 28.96% year-over-year to -$14.4 million; the TTM value through Dec 2025 reached -$55.3 million, up 33.94%, while the annual FY2025 figure was -$54.7 million, 34.72% up from the prior year.
- Net Income hit -$14.4 million in Q4 2025 for Kezar Life Sciences, down from -$10.7 million in the prior quarter.
- Across five years, Net Income topped out at -$10.7 million in Q3 2025 and bottomed at -$32.3 million in Q4 2023.
- Average Net Income over 5 years is -$18.2 million, with a median of -$17.2 million recorded in 2022.
- Year-over-year, Net Income crashed 77.44% in 2023 and then soared 47.38% in 2025.
- Kezar Life Sciences' Net Income stood at -$14.2 million in 2021, then dropped by 27.93% to -$18.2 million in 2022, then plummeted by 77.44% to -$32.3 million in 2023, then soared by 37.33% to -$20.2 million in 2024, then rose by 28.96% to -$14.4 million in 2025.
- According to Business Quant data, Net Income over the past three periods came in at -$14.4 million, -$10.7 million, and -$13.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.